Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A David Burden

Showing results (11-20 of 55) with videos related to

Pageof 6
Sort By:
Dermatology and Therapy|September 21, 2023
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding StudyA David Burden, Robert Bissonnette, Alexander A Navarini, et al.
Dermatology (Basel, Switzerland)|February 16, 2023
Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis FlaresSiew Eng Choon, Mark G Lebwohl, Hamida Turki, et al.
Journal of the American Academy of Dermatology|August 13, 2008
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trialGregor B E Jemec, Cecilia Ganslandt, Jean-Paul Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 1, 2023
Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI)A David Burden, Robert Bissonnette, Mark G Lebwohl, et al.
BMC Rheumatology|May 17, 2021
The BSR-PsA: study protocol for the British Society for Rheumatology psoriatic arthritis registerGareth T Jones, Gary J Macfarlane, Karen Forrest Keenan, et al.
Brain, Behavior, and Immunity|August 11, 2015
Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humansRajeev Krishnadas, Alice Nicol, Jen Sassarini, et al.
Dermatology and Therapy|March 4, 2021
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot StudyUlrich Mrowietz, A David Burden, Andreas Pinter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 9, 2024
Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasisA David Burden, Robert Bissonnette, Milena Anatchkova, et al.
Dermatology and Therapy|November 5, 2022
Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular PsoriasisAkimichi Morita, Siew Eng Choon, Hervé Bachelez, et al.
The Journal of Investigative Dermatology|August 30, 2016
Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2Kave Shams, Gillian J Wilson, Mark Singh, et al.
Pageof 6

Showing results (11-20 of 55) with videos related to

Sort By:
Pageof 6
Dermatology and Therapy|September 21, 2023
Spesolimab Efficacy and Safety in Patients with Moderate-to-Severe Palmoplantar Pustulosis: A Multicentre, Double-Blind, Randomised, Placebo-Controlled, Phase IIb, Dose-Finding StudyA David Burden, Robert Bissonnette, Alexander A Navarini, et al.
Dermatology (Basel, Switzerland)|February 16, 2023
Clinical Characteristics and Outcomes of Generalized Pustular Psoriasis FlaresSiew Eng Choon, Mark G Lebwohl, Hamida Turki, et al.
Journal of the American Academy of Dermatology|August 13, 2008
A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trialGregor B E Jemec, Cecilia Ganslandt, Jean-Paul Ortonne, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 1, 2023
Psychometric validation of the generalized pustular psoriasis physician global assessment (GPPGA) and generalized pustular psoriasis area and severity index (GPPASI)A David Burden, Robert Bissonnette, Mark G Lebwohl, et al.
BMC Rheumatology|May 17, 2021
The BSR-PsA: study protocol for the British Society for Rheumatology psoriatic arthritis registerGareth T Jones, Gary J Macfarlane, Karen Forrest Keenan, et al.
Brain, Behavior, and Immunity|August 11, 2015
Circulating tumour necrosis factor is highly correlated with brainstem serotonin transporter availability in humansRajeev Krishnadas, Alice Nicol, Jen Sassarini, et al.
Dermatology and Therapy|March 4, 2021
Spesolimab, an Anti-Interleukin-36 Receptor Antibody, in Patients with Palmoplantar Pustulosis: Results of a Phase IIa, Multicenter, Double-Blind, Randomized, Placebo-Controlled Pilot StudyUlrich Mrowietz, A David Burden, Andreas Pinter, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 9, 2024
Psychometric validation of the Psoriasis Symptom Scale, Functional Assessment of Chronic Illness Therapy-Fatigue and pain-Visual Analogue Scale in patients with generalized pustular psoriasisA David Burden, Robert Bissonnette, Milena Anatchkova, et al.
Dermatology and Therapy|November 5, 2022
Design of Effisayil™ 2: A Randomized, Double-Blind, Placebo-Controlled Study of Spesolimab in Preventing Flares in Patients with Generalized Pustular PsoriasisAkimichi Morita, Siew Eng Choon, Hervé Bachelez, et al.
The Journal of Investigative Dermatology|August 30, 2016
Spread of Psoriasiform Inflammation to Remote Tissues Is Restricted by the Atypical Chemokine Receptor ACKR2Kave Shams, Gillian J Wilson, Mark Singh, et al.
Pageof 6